CN114940964A - 工程菌及其高效催化cdca生产udca的方法 - Google Patents

工程菌及其高效催化cdca生产udca的方法 Download PDF

Info

Publication number
CN114940964A
CN114940964A CN202210556251.2A CN202210556251A CN114940964A CN 114940964 A CN114940964 A CN 114940964A CN 202210556251 A CN202210556251 A CN 202210556251A CN 114940964 A CN114940964 A CN 114940964A
Authority
CN
China
Prior art keywords
hsdh
ala
gene
leu
glu
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202210556251.2A
Other languages
English (en)
Other versions
CN114940964B (zh
Inventor
朱俊歌
吴胜
陶勇
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institute of Microbiology of CAS
Original Assignee
Institute of Microbiology of CAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institute of Microbiology of CAS filed Critical Institute of Microbiology of CAS
Priority to CN202210556251.2A priority Critical patent/CN114940964B/zh
Publication of CN114940964A publication Critical patent/CN114940964A/zh
Application granted granted Critical
Publication of CN114940964B publication Critical patent/CN114940964B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0006Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52Genes encoding for enzymes or proenzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0012Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
    • C12N9/0014Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on the CH-NH2 group of donors (1.4)
    • C12N9/0016Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on the CH-NH2 group of donors (1.4) with NAD or NADP as acceptor (1.4.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/90Isomerases (5.)
    • C12N9/92Glucose isomerase (5.3.1.5; 5.3.1.9; 5.3.1.18)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P33/00Preparation of steroids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/002Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by oxidation/reduction reactions
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y101/00Oxidoreductases acting on the CH-OH group of donors (1.1)
    • C12Y101/01Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
    • C12Y101/01027L-Lactate dehydrogenase (1.1.1.27)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y101/00Oxidoreductases acting on the CH-OH group of donors (1.1)
    • C12Y101/01Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
    • C12Y101/011597-Alpha-hydroxysteroid dehydrogenase (1.1.1.159)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y101/00Oxidoreductases acting on the CH-OH group of donors (1.1)
    • C12Y101/01Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
    • C12Y101/012017-Beta-hydroxysteroid dehydrogenase (NADP+) (1.1.1.201)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y104/00Oxidoreductases acting on the CH-NH2 group of donors (1.4)
    • C12Y104/01Oxidoreductases acting on the CH-NH2 group of donors (1.4) with NAD+ or NADP+ as acceptor (1.4.1)
    • C12Y104/01002Glutamate dehydrogenase (1.4.1.2)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y306/00Hydrolases acting on acid anhydrides (3.6)
    • C12Y306/01Hydrolases acting on acid anhydrides (3.6) in phosphorus-containing anhydrides (3.6.1)
    • C12Y306/01009Nucleotide diphosphatase (3.6.1.9), i.e. nucleotide-pyrophosphatase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y503/00Intramolecular oxidoreductases (5.3)
    • C12Y503/01Intramolecular oxidoreductases (5.3) interconverting aldoses and ketoses (5.3.1)
    • C12Y503/01009Glucose-6-phosphate isomerase (5.3.1.9)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/185Escherichia
    • C12R2001/19Escherichia coli
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/584Recycling of catalysts

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

本发明属于生物催化技术领域,本发明公开了一种工程菌及其高效催化CDCA生产UDCA的方法。本发明以大肠杆菌BW25113作为出发菌株,通过敲除基因,得到两株能够显著提高内源辅酶NAD(P)H转换效率的底盘菌株ΔmazG BW25113和Δpgi BW25113。在此基础上,将7α‑HSDH‑LDH和7β‑HSDH‑GDH在底盘菌株中异源表达,并构建辅酶循环再生体系,串联高效催化生产熊去氧胆酸(UDCA)。底物是鹅去氧胆酸(CDCA),投料高达150g/L,转化率≥99.0%,产物纯度≥98.5%,且无任何副产物生成。本发明技术方案通过高效生物催化CDCA生产UDCA的方法,具有生产成本低、反应温和、转化率高、生产效率高等特点,是熊去氧胆酸工业化生产的优选之路。

Description

工程菌及其高效催化CDCA生产UDCA的方法
技术领域
本发明属于生物催化技术领域。
背景技术
熊去氧胆酸(UDCA),化学名称为3α,7β-二羟基-5β-胆甾烷-24-酸,是名贵中药熊胆所含的主要有效成分,在临床上主要用于治疗各种胆石疾病,急性、慢性肝病,是美国FDA批准治疗原发性胆汁性肝硬化疾病的唯一药物。近年来,随着对UDCA的深入研究,发现其还具有细胞保护、免疫调节及抗癌作用,因此,UDCA作为保健品应用在日常保健领域。鉴于UDCA在治疗肝胆类等疾病方面疗效强、副作用小的优点,UDCA的市场需求每年呈递增趋势。
传统获得UDCA的方式是从人工养殖熊胆汁中提取,由最初的“有管引流”发展到“无管引流”,鉴于熊胆中获取UDCA含量有限,且有违于动物保护,因此如何实现UDCA的人工合成具有重要意义。目前UDCA的合成主要有两种方式:1)化学合成,包括常规的化学合成和电化学催化两种方法。如专利CN111072744A以胆酸作为原料,经过保护基团、氧化、还原等步骤合成UDCA。专利CN106868534A则以纯金反应电极,纳米钯作为催化剂,通过电催化的方式制备UDCA。化学合成的特点是涉及步骤较多、立体选择性差、或需要使用重金属作为催化剂。2)生物合成,即以胆酸或鹅去氧胆酸作为原料,通过酶/细胞催化制备UDCA。目前关于生物合成UDCA的报道较多,如专利CN105861613A、CN112725212A等均以鹅去氧胆酸为底物,在添加辅因子的前提下,通过7α-HSDH和7β-HSDH催化生成UDCA。生物合成相比于化学合成成本较低,且有步骤少、污染小、易操作等特点,是规模化生产UDCA的发展方向。目前报道的绝大多数生物合成UDCA的方法,需要额外添加辅因子来提高底物的投料量,鉴于辅因子在生产UDCA的重要性以及其居高不下的市场价格,迫切需要开发新的工艺实现高投料,低成本的模式生产UDCA。
发明内容
有鉴于此,本发明克服现有技术中的不足,以大肠杆菌BW25113为出发菌株,通过敲除关键基因获得提高内源辅因子转换效率的底盘菌株,实现7α-HSDH-LDH和7β-HSDH-GDH的异源表达,并构建辅因子再生循环体系串联高效生产UDCA。
本发明的目的是提供了一株工程菌7α-HSDH-LDH-ΔmazG BW25113,所述工程菌7α-HSDH-LDH-ΔmazG BW25113由含有7α-HSDH基因片段和LDH基因片段的质粒载体转入敲除mazG基因片段的底盘菌株中获得;所述含有7α-HSDH基因片段和LDH基因片段的质粒载体是由7α-HSDH基因和LDH基因导入pBAD质粒载体获得;所述敲除mazG基因片段的底盘菌株是由大肠杆菌BW25113菌株敲除mazG基因获得;所述敲除mazG基因的技术为Red-同源重组技术;所述7α-HSDH基因具有SEQ ID NO.6所示的氨基酸序列;所述LDH基因具有SEQ ID NO.8所示的氨基酸序列;所述mazG基因具有SEQ ID NO.2所示的氨基酸序列。
本发明另外一个目的还提供了一种全细胞催化CDCA生产UDCA的方法,包括如下步骤:权利要求1所述工程菌7α-HSDH-LDH-ΔmazG BW25113催化鹅去氧胆酸转变成中间体7-酮石胆酸;工程菌7β-HSDH-GDH-Δpgi BW25113催化中间体7-酮石胆酸转变成熊去氧胆酸。
在本发明的具体实施方式中,所述工程菌7α-HSDH-LDH-ΔmazG BW25113催化鹅去氧胆酸转变成中间体7-酮石胆酸包括如下步骤:PB缓冲溶液中加入全细胞催化剂菌体7α-HSDH-LDH-ΔmazG BW25113,加入CDCA和丙酮酸钠,控制反应条件生成中间体7-酮石胆酸。
在本发明的具体实施方式中,所述工程菌7β-HSDH-GDH-Δpgi BW25113催化中间体7-酮石胆酸转变成熊去氧胆酸包括如下步骤:在中间体7-酮石胆酸的反应溶液中加入工程菌7β-HSDH-GDH-Δpgi BW25113,加入葡萄糖,控制反应条件生成熊去氧胆酸。
在本发明的具体实施方式中,所述工程菌7β-HSDH-GDH-Δpgi BW25113由含有7β-HSDH基因片段和GDH基因片段的质粒载体转入敲除pgi基因片段的底盘菌株中获得;所述含有7β-HSDH基因片段和GDH基因片段的质粒载体是由7β-HSDH基因和GDH基因导入pBAD质粒载体获得;所述敲除pgi基因片段的底盘菌株是由大肠杆菌BW25113菌株敲除pgi基因获得;所述敲除pgi基因的技术为Red-同源重组技术;所述7β-HSDH基因具有SEQ ID NO.10所示的氨基酸序列;所述GDH基因具有SEQ ID NO.12所示的氨基酸序列;所述pgi基因具有SEQ IDNO.4所示的氨基酸序列。
本发明与现有的技术相比,具有以下有益效果:
(1)本发明以大肠杆菌BW25113为出发菌株,通过敲除靶基因ΔmazG、Δpgi,增加了细胞中内源辅酶NAD(P)H的产量,并构建辅酶再生体系高效全细胞催化生产UDCA,因此无需额外添加昂贵的辅酶,比现有已报道的生物催化的成本明显减低。
(2)底物浓度高达150g/L,反应时间短,操作简单,底物转化率≥99%,纯度≥98.5%,且无任何副产物生成。
(3)底物投料高、生产成本低、反应温和、转化率高、生产效率高。
附图说明
图1.催化鹅去氧胆酸生产熊去氧胆酸的原理图。
图2. 7α-HSDH-LDH-ΔmazG BW25113共表达蛋白图。
图3. 7β-HSDH-GDH-Δpgi BW25113共表达蛋白图。
图4. 7-酮石胆酸熊高效液相色谱图。
图5.UDCA高效液相色谱图。
具体实施方式
以下结合实施例对本发明作进一步详细说明,但并不因此将本发明限制在所述的实施例范围之中。
大肠杆菌BW25113菌株购自上海泽叶生物科技有限公司。
pKD46和pCP20质粒购自北京润泽康生物科技有限公司。
pBAD载体购自北京庄盟国际生物基因科技有限公司。
5×蛋白胶上样缓冲液购自北京华博德亿生物技术有限公司。
SDS-PAGE蛋白分离胶制备参考《分子生物学实验指南》。
未特别说明的实验步骤均按照试剂说明书操作。
实施例1
底盘菌株ΔmazG BW25113、Δpgi BW25113的构建
利用Red-同源重组技术,将按照以下步骤构建相应底盘菌株
1.ΔmazG BW25113底盘菌株的构建,步骤如下:
(1)准备打靶片段。
以大肠杆菌BW25113菌株为模板,设计基于mazG基因的PCR扩增引物。所述mazG基因的核苷酸序列如SEQ ID NO.1所示和氨基酸序列如SEQ ID NO.2所示。打靶片段的PCR扩增引物上下游均含有长约30bp的同源序列。
(2)制备pKD46-BW25113电转感受态细胞。
将质粒pKD46转入BW25113感受态细胞中。按照电转化操作流程,获得pKD46-BW25113电转感受态细胞。
(3)电转化打靶片段。
按照电转操作流程,将步骤(1)中的打靶片段转入步骤(2)中制备的pKD46-BW25113感受态细胞中,30℃、150r/min培养1h后,涂含卡那抗性的LB平板,30℃静置培养过夜。
(4)消除抗性。
按照化转感受态制备过程获得kana-ΔmazG BW25113感受态细胞,转入含氨苄抗性pCP20质粒,LB平板静置培养过夜后,随机挑取单菌落转入5mlLLB液体试管中,加入质量浓度0.5%L-阿拉伯糖培养10h后涂卡那抗性LB平板,无菌斑明显出现的平板表明ΔmazG基因敲除成功。
2.Δpgi BW25113底盘菌株的构建,步骤如下:
(1)准备打靶片段。
以大肠杆菌BW25113菌株为模板,设计基于pgi基因的PCR扩增引物。所述pgi基因的核苷酸序列如SEQ ID NO.3所示和氨基酸序列如SEQ ID NO.4所示。打靶片段的PCR扩增引物上下游均含有长约30bp的同源序列。
(2)制备pKD46-BW25113电转感受态细胞。
将质粒pKD46转入BW25113感受态细胞中,按照电转化操作流程,获得pKD46-BW25113电转感受态细胞。
(3)电转化打靶片段。
按照电转操作流程,将步骤(1)中的打靶片段转入步骤(2)中制备的pKD46-BW25113感受态细胞中,30℃、150r/min培养1h后,涂含卡那抗性的LB平板,30℃静置培养过夜。
(4)消除抗性。
按照化转感受态制备过程获得kana-ΔmazG BW25113感受态细胞,转入含氨苄抗性pCP20质粒,LB平板静置培养过夜后,随机挑取单菌落转入5mlLLB液体试管中,加入质量浓度0.5%L-阿拉伯糖培养10h后涂卡那抗性LB平板,无菌斑明显出现的平板表明Δpgi基因敲除成功。
实施例2
工程菌的构建
1.pBAD-7α-HSDH-LDH质粒载体的构建
Psychrobacter sp.G的7α-HSDH基因;所述7α-HSDH基因的核苷酸序列如SEQ IDNO.5所示和氨基酸序列如SEQ ID NO.6所示。
Escherichia coli K-12的LDH基因,所述LDH基因的核苷酸序列如SEQ ID NO.7所示和氨基酸序列如SEQ ID NO.8所示。
分别设计7α-HSDH基因引物对5’-catgccatggattctccgcagagtcatttt-3’和5’-ccctcgagttaatccagggtctgaacaccg-3’,以及LDH基因引物对5’-ccctcgagtctagagaaagaggggacaaactagatgaaactcgccgtttatagcacaaaa-3’和5’-ggaattcttaaaccagttcgttcgggcaggtttcgcctttttccagattgcttaagttt-3’,通过PCR进行扩增,用NcoI、XhoI和XhoI、EcoRI进行酶切,PCR得到的基因序列两端分别带有NcoI、XhoI和XhoI、EcoRI两个酶切位点,PCR产物经琼脂糖凝胶电泳纯化,利用琼脂糖凝胶DNA回收试剂盒回收目的片段。NcoI、EcoRI酶切pBAD载体,用T4连接酶连接7α-HSDH、LDH片段和pBAD线性载体,连接产物转化DH5α后涂卡那霉素抗性平板,过夜培养后挑单菌落至装有5mL LB的试管培养,用质粒提取试剂盒提取质粒,PCR扩增确定插入基因条带大小正确的质粒送测序,保存测序正确的质粒并命名为pBAD-7α-HSDH-LDH。
2.pBAD-7β-HSDH-GDH质粒载体的构建
Ruminococcus gnavu(ATCC 29149)的7β-HSDH基因,所述7β-HSDH基因的核苷酸序列如SEQ ID NO.9所示和氨基酸序列如SEQ ID NO.10所示。
Bacillus megateriu(ATCC 14581)的GDH基因,所述GDH基因的核苷酸序列如SEQID NO.11所示和氨基酸序列如SEQ ID NO.12所示。
分别设计7β-HSDH基因引物对5’-ctagctagcatgacattgagagaaaaatat-3’和5’-ccctcgagttcttgatagaaagatcccata-3’,以及GDH基因引物对5’-ccctcgagtctagagaaagaggggacaaactagatgtatacagatttaaaagataaag-3’和5’-ggggtaccttagcctcttcctgcttggaaagaagggtacagcgtcataccaccatcagca-3’,通过PCR进行扩增,用NheI、XhoI和XhoI、KpnI进行酶切,PCR得到的基因序列两端分别带有NheI、XhoI和XhoI、KpnI两个酶切位点,PCR产物经琼脂糖凝胶电泳纯化,利用琼脂糖凝胶DNA回收试剂盒回收目的片段。NheI、KpnI酶切pBAD载体,用T4连接酶7β-HSDH、GDH片段和pBAD线性载体,连接产物转化DH5α后涂卡那霉素抗性平板,过夜培养后挑单菌落至装有5mL LB的试管培养,用质粒提取试剂盒提取质粒,PCR扩增确定插入基因条带大小正确的质粒送测序,保存测序正确的质粒并命名为pBAD-7β-HSDH-GDH。
3.工程菌的转化
按照质粒化学转化常规方法,将构建的表达载体分别转入ΔmazG BW25113和Δpgi BW25113感受态细胞中,得到工程菌7α-HSDH-LDH-ΔmazG BW25113和7β-HSDH-GDH-Δpgi BW25113。
(1)工程菌7α-HSDH-LDH-BW25113的构建
取100μL的感受态细胞ΔmazG BW25113,将1μL的pBAD-7α-HSDH-LDH质粒加入感受态细胞中,轻柔混匀。后冰浴30min,42℃热激90s后,再迅速冰浴2min。向每个离心管中加入500μL无菌无抗的LB培养基,混匀后置于37℃摇床恒温振荡培养45min使菌体复苏;吸取100μL涂布LB固体培养基(kan抗性),37℃培养12~16h,获得7α-HSDH-LDH-ΔmazG BW25113工程菌,以甘油管形式保存菌种。
(2)7β-HSDH-GDH-Δpgi BW25113工程菌的构建
取100μL的感受态细胞Δpgi BW25113,将1μL的pBAD-7β-HSDH-GDH质粒加入感受态细胞中,轻柔混匀。后冰浴30min,42℃热激90s后,再迅速冰浴2min。向每个离心管中加入500μL无菌无抗的LB培养基,混匀后置于37℃摇床恒温振荡培养45min使菌体复苏;吸取100μL涂布LB固体培养基(kan抗性),37℃培养12~16h,获得7β-HSDH-GDH-Δpgi BW25113工程菌并以甘油管形式保存菌种。
实施例3
工程菌的发酵培养
1.工程菌7α-HSDH-LDH-ΔmazG BW25113的制备
(1)种子培养基活化:吸取甘油菌种管中7α-HSDH-LDH-ΔmazG BW25113于5mL,含100μg/mL卡那霉素的LB培养基中,37℃、200rpm过夜活化。
(2)发酵培养:将过夜活化的种子液分别按1%体积比比例接种到800mL,含100μg/mL卡那霉素的TB发酵培养基,37℃、200rpm培养至对数中期OD600=0.6左右。
(3)诱导培养:25℃、200rpm下加入质量浓度1%L-阿拉伯糖进行诱导培养8-10h,离心收集细胞。
(4)SDS-PAGE:取诱导完成的发酵液0.5mL,12000rpm离心90s,加入200μL上样缓冲液;SDS-PAGE分离胶浓度为12.5%,每孔上样5μL。
工程菌7α-HSDH-LDH-ΔmazG BW25113共表达蛋白见图2。
2.工程菌7β-HSDH-GDH-Δpgi BW25113的制备
(1)种子培养基活化:吸取甘油菌种管中7β-HSDH-GDH-Δpgi BW25113于5mL,含100μg/mL卡那霉素的LB培养基中,37℃、200rpm过夜活化。
(2)发酵培养:将过夜活化的种子液分别按1%体积比比例接种到800mL,含100μg/mL卡那霉素的TB发酵培养基,37℃、200rpm培养至对数中期OD600=0.6左右。
(3)诱导培养:25℃、200rpm下加入质量浓度1%L-阿拉伯糖进行诱导培养8-10h,离心收集细胞。
(4)SDS-PAGE:取诱导完成的发酵液0.5mL,12000rpm离心90s,加入200μL上样缓冲液;SDS-PAGE分离胶浓度为12.5%,每孔上样5μL。
工程菌7β-HSDH-GDH-Δpgi BW25113共表达蛋白见图3。
实施例4
全细胞催化CDCA生产UDCA
(1)工程菌7α-HSDH-LDH-ΔmazG BW25113催化鹅去氧胆酸转变成中间体7-酮石胆酸
在50mM,pH7.5、10mL的PB缓冲溶液中加入实施例3制备的全细胞催化剂菌体7α-HSDH-LDH-ΔmazG BW25113 0.5g,加入底物CDCA 1.5g,加入底物CDCA投料量5倍的丙酮酸钠(摩尔比),控制pH在7.5、30℃的条件反应进行,HPLC监控反应进程中7-酮石胆酸的生成。
7-酮石胆酸的检测分析方法:取上述样品溶液300μl,12000rpm/min离心后取上清溶液,用0.22um水相过滤器过滤,使用高效液相色谱仪分析,所用色谱柱为Agilent ZORBAXC18 3.5μm色谱柱,流动相为乙腈:甲酸水溶液(pH 4.0)=50:50,流速1.0mL/min,色谱柱温度为40℃,λmax=210nm。
(2)工程菌7β-HSDH-GDH-Δpgi BW25113催化中间体7-酮石胆酸转变成熊去氧胆酸
在实施例4(1)制备的中间体7-酮石胆酸的反应溶液中加入实施例3制备的工程菌7β-HSDH-GDH-Δpgi BW25113 0.5g,加入1倍于底物CDCA投料量的葡萄糖(摩尔比),保持反应体系在pH7.5、30℃的条件下继续进行,HPLC监控反应进程中7-酮石胆酸完全转变成熊去氧胆酸,终止反应。
熊去氧胆酸的检测分析方法:取上述样品溶液300μl,12000rpm/min离心后取上清溶液,用0.22um水相过滤器过滤,使用高效液相色谱仪分析,所用色谱柱为Agilent ZORBAXC18 3.5μm色谱柱,流动相为乙腈:甲酸水溶液(pH 5.0=50:50,流速1.0ml/min,色谱柱温度为40℃,λmax=210nm。
(3)熊去氧胆酸的制备
反应后的溶液加入等量终反应体积的乙酸乙酯萃取3次,合并有机相,加入无水Na2SO4过夜干燥后旋蒸至恒重,即可得到熊去氧胆酸粗品147.7g。将粗品溶于丙酮,回流1h后缓慢冷却结晶即可获得熊去氧胆酸纯品145.2g,纯度为98.5%。
以上所述仅是本发明的优选实施方式,本发明的保护范围并不仅局限于上述实施例,凡属于本发明思路下的技术方案均属于本发明的保护范围。应当指出,对于本技术领域的普通技术人员来说,在不脱离本发明原理前提下的若干改进和润饰,这些改进和润饰也应视为本发明的保护范围。
序列表
<110> 中国科学院微生物研究所
<120> 工程菌及其高效催化CDCA生产UDCA的方法
<130> IM2022027I
<160> 12
<170> SIPOSequenceListing 1.0
<210> 1
<211> 792
<212> DNA
<213> 大肠杆菌(bacillus coli)
<400> 1
atgaatcaaa tcgaccgttt gctcactatt atgcagcgcc tgcgcgatcc ggaaaacggc 60
tgcccgtggg ataaagagca gacatttgcc accattgcgc cttacaccct tgaagaaacc 120
tacgaagtgc tggacgccat cgcccgtgaa gattttgacg atcttcgcgg tgaactgggc 180
gatctgctat tccaggtggt gttttacgcg caaatggctc aggaagaagg gcgctttgac 240
tttaatgata tttgcgctgc tattagcgat aaattagagc gtcgccatcc gcatgttttt 300
gctgatagtt ctgccgaaaa cagtagtgaa gtgcttgccc gttgggagca aatcaaaacc 360
gaagagcgcg cgcagaaagc gcagcattcg gcgctggacg atattcctcg tagtttaccg 420
gctttaatgc gtgcgcaaaa aatccagaaa cgttgcgcca acgttggctt cgattggacg 480
acgcttggtc cggtagtcga taaagtctac gaagagatcg acgaggtgat gtacgaagcg 540
cggcaggctg ttgtcgacca ggctaaactg gaggaggaaa tgggggacct gctgtttgcc 600
acggttaatc tggctcgcca tttagggacg aaagcagaaa tcgcattgca aaaagcgaac 660
gaaaaattcg agcgtcgttt tcgcgaagtg gagcgtattg ttgccgcgcg tggactggaa 720
atgacaggtg ttgacctcga aacaatggaa gaagtctggc aacaggtaaa acggcaggaa 780
attgatctct aa 792
<210> 2
<211> 263
<212> PRT
<213> 大肠杆菌(bacillus coli)
<400> 2
Met Asn Gln Ile Asp Arg Leu Leu Thr Ile Met Gln Arg Leu Arg Asp
1 5 10 15
Pro Glu Asn Gly Cys Pro Trp Asp Lys Glu Gln Thr Phe Ala Thr Ile
20 25 30
Ala Pro Tyr Thr Leu Glu Glu Thr Tyr Glu Val Leu Asp Ala Ile Ala
35 40 45
Arg Glu Asp Phe Asp Asp Leu Arg Gly Glu Leu Gly Asp Leu Leu Phe
50 55 60
Gln Val Val Phe Tyr Ala Gln Met Ala Gln Glu Glu Gly Arg Phe Asp
65 70 75 80
Phe Asn Asp Ile Cys Ala Ala Ile Ser Asp Lys Leu Glu Arg Arg His
85 90 95
Pro His Val Phe Ala Asp Ser Ser Ala Glu Asn Ser Ser Glu Val Leu
100 105 110
Ala Arg Trp Glu Gln Ile Lys Thr Glu Glu Arg Ala Gln Lys Ala Gln
115 120 125
His Ser Ala Leu Asp Asp Ile Pro Arg Ser Leu Pro Ala Leu Met Arg
130 135 140
Ala Gln Lys Ile Gln Lys Arg Cys Ala Asn Val Gly Phe Asp Trp Thr
145 150 155 160
Thr Leu Gly Pro Val Val Asp Lys Val Tyr Glu Glu Ile Asp Glu Val
165 170 175
Met Tyr Glu Ala Arg Gln Ala Val Val Asp Gln Ala Lys Leu Glu Glu
180 185 190
Glu Met Gly Asp Leu Leu Phe Ala Thr Val Asn Leu Ala Arg His Leu
195 200 205
Gly Thr Lys Ala Glu Ile Ala Leu Gln Lys Ala Asn Glu Lys Phe Glu
210 215 220
Arg Arg Phe Arg Glu Val Glu Arg Ile Val Ala Ala Arg Gly Leu Glu
225 230 235 240
Met Thr Gly Val Asp Leu Glu Thr Met Glu Glu Val Trp Gln Gln Val
245 250 255
Lys Arg Gln Glu Ile Asp Leu
260
<210> 3
<211> 1650
<212> DNA
<213> 大肠杆菌(bacillus coli)
<400> 3
atgaaaaaca tcaatccaac gcagaccgct gcctggcagg cactacagaa acacttcgat 60
gaaatgaaag acgttacgat cgccgatctt tttgctaaag acggcgatcg tttttctaag 120
ttctccgcaa ccttcgacga tcagatgctg gtggattact ccaaaaaccg catcactgaa 180
gagacgctgg cgaaattaca ggatctggcg aaagagtgcg atctggcggg cgcgattaag 240
tcgatgttct ctggcgagaa gatcaaccgc actgaaaacc gcgccgtgct gcacgtagcg 300
ctgcgtaacc gtagcaatac cccgattttg gttgatggca aagacgtaat gccggaagtc 360
aacgcggtgc tggagaagat gaaaaccttc tcagaagcga ttatttccgg tgagtggaaa 420
ggttataccg gcaaagcaat cactgacgta gtgaacatcg ggatcggcgg ttctgacctc 480
ggcccataca tggtgaccga agctctgcgt ccgtacaaaa accacctgaa catgcacttt 540
gtttctaacg tcgatgggac tcacatcgcg gaagtgctga aaaaagtaaa cccggaaacc 600
acgctgttct tggtagcatc taaaaccttc accactcagg aaactatgac caacgcccat 660
agcgcgcgtg actggttcct gaaagcggca ggtgatgaaa aacacgttgc aaaacacttt 720
gcggcgcttt ccaccaatgc caaagccgtt ggcgagtttg gtattgatac tgccaacatg 780
ttcgagttct gggactgggt tggcggccgt tactctttgt ggtcagcgat tggcctgtcg 840
attgttctct ccatcggctt tgataacttc gttgaactgc tttccggcgc acacgcgatg 900
gacaagcatt tctccaccac gcctgccgag aaaaacctgc ctgtactgct ggcgctgatt 960
ggcatctggt acaacaattt ctttggtgcg gaaactgaag cgattctgcc gtatgaccag 1020
tatatgcacc gtttcgcggc gtacttccag cagggcaata tggagtccaa cggtaagtat 1080
gttgaccgta acggtaacgt tgtggattac cagactggcc cgattatctg gggtgaacca 1140
ggcactaacg gtcagcacgc gttctaccag ctgatccacc agggaaccaa aatggtaccg 1200
tgcgatttca tcgctccggc tatcacccat aacccgctct ctgatcatca ccagaaactg 1260
ctgtctaact tcttcgccca gaccgaagcg ctggcgtttg gtaaatcccg cgaagtggtt 1320
gagcaggaat atcgtgatca gggtaaagat ccggcaacgc ttgactacgt ggtgccgttc 1380
aaagtattcg aaggtaaccg cccgaccaac tccatcctgc tgcgtgaaat cactccgttc 1440
agcctgggtg cgttgattgc gctgtatgag cacaaaatct ttactcaggg cgtgatcctg 1500
aacatcttca ccttcgacca gtggggcgtg gaactgggta aacagctggc gaaccgtatt 1560
ctgccagagc tgaaagatga taaagaaatc agcagccacg atagctcgac caatggtctg 1620
attaaccgct ataaagcgtg gcgcggttaa 1650
<210> 4
<211> 549
<212> PRT
<213> 大肠杆菌(bacillus coli)
<400> 4
Met Lys Asn Ile Asn Pro Thr Gln Thr Ala Ala Trp Gln Ala Leu Gln
1 5 10 15
Lys His Phe Asp Glu Met Lys Asp Val Thr Ile Ala Asp Leu Phe Ala
20 25 30
Lys Asp Gly Asp Arg Phe Ser Lys Phe Ser Ala Thr Phe Asp Asp Gln
35 40 45
Met Leu Val Asp Tyr Ser Lys Asn Arg Ile Thr Glu Glu Thr Leu Ala
50 55 60
Lys Leu Gln Asp Leu Ala Lys Glu Cys Asp Leu Ala Gly Ala Ile Lys
65 70 75 80
Ser Met Phe Ser Gly Glu Lys Ile Asn Arg Thr Glu Asn Arg Ala Val
85 90 95
Leu His Val Ala Leu Arg Asn Arg Ser Asn Thr Pro Ile Leu Val Asp
100 105 110
Gly Lys Asp Val Met Pro Glu Val Asn Ala Val Leu Glu Lys Met Lys
115 120 125
Thr Phe Ser Glu Ala Ile Ile Ser Gly Glu Trp Lys Gly Tyr Thr Gly
130 135 140
Lys Ala Ile Thr Asp Val Val Asn Ile Gly Ile Gly Gly Ser Asp Leu
145 150 155 160
Gly Pro Tyr Met Val Thr Glu Ala Leu Arg Pro Tyr Lys Asn His Leu
165 170 175
Asn Met His Phe Val Ser Asn Val Asp Gly Thr His Ile Ala Glu Val
180 185 190
Leu Lys Lys Val Asn Pro Glu Thr Thr Leu Phe Leu Val Ala Ser Lys
195 200 205
Thr Phe Thr Thr Gln Glu Thr Met Thr Asn Ala His Ser Ala Arg Asp
210 215 220
Trp Phe Leu Lys Ala Ala Gly Asp Glu Lys His Val Ala Lys His Phe
225 230 235 240
Ala Ala Leu Ser Thr Asn Ala Lys Ala Val Gly Glu Phe Gly Ile Asp
245 250 255
Thr Ala Asn Met Phe Glu Phe Trp Asp Trp Val Gly Gly Arg Tyr Ser
260 265 270
Leu Trp Ser Ala Ile Gly Leu Ser Ile Val Leu Ser Ile Gly Phe Asp
275 280 285
Asn Phe Val Glu Leu Leu Ser Gly Ala His Ala Met Asp Lys His Phe
290 295 300
Ser Thr Thr Pro Ala Glu Lys Asn Leu Pro Val Leu Leu Ala Leu Ile
305 310 315 320
Gly Ile Trp Tyr Asn Asn Phe Phe Gly Ala Glu Thr Glu Ala Ile Leu
325 330 335
Pro Tyr Asp Gln Tyr Met His Arg Phe Ala Ala Tyr Phe Gln Gln Gly
340 345 350
Asn Met Glu Ser Asn Gly Lys Tyr Val Asp Arg Asn Gly Asn Val Val
355 360 365
Asp Tyr Gln Thr Gly Pro Ile Ile Trp Gly Glu Pro Gly Thr Asn Gly
370 375 380
Gln His Ala Phe Tyr Gln Leu Ile His Gln Gly Thr Lys Met Val Pro
385 390 395 400
Cys Asp Phe Ile Ala Pro Ala Ile Thr His Asn Pro Leu Ser Asp His
405 410 415
His Gln Lys Leu Leu Ser Asn Phe Phe Ala Gln Thr Glu Ala Leu Ala
420 425 430
Phe Gly Lys Ser Arg Glu Val Val Glu Gln Glu Tyr Arg Asp Gln Gly
435 440 445
Lys Asp Pro Ala Thr Leu Asp Tyr Val Val Pro Phe Lys Val Phe Glu
450 455 460
Gly Asn Arg Pro Thr Asn Ser Ile Leu Leu Arg Glu Ile Thr Pro Phe
465 470 475 480
Ser Leu Gly Ala Leu Ile Ala Leu Tyr Glu His Lys Ile Phe Thr Gln
485 490 495
Gly Val Ile Leu Asn Ile Phe Thr Phe Asp Gln Trp Gly Val Glu Leu
500 505 510
Gly Lys Gln Leu Ala Asn Arg Ile Leu Pro Glu Leu Lys Asp Asp Lys
515 520 525
Glu Ile Ser Ser His Asp Ser Ser Thr Asn Gly Leu Ile Asn Arg Tyr
530 535 540
Lys Ala Trp Arg Gly
545
<210> 5
<211> 768
<212> DNA
<213> 大肠埃希氏杆菌(Escherichia coli)
<400> 5
gtgtttaatt ctgacaacct gagactcgac ggaaaatgcg ccatcatcac aggtgcgggt 60
gcaggtattg gtaaagaaat cgccattaca ttcgcgacag ctggcgcatc tgtggtggtc 120
agtgatatta acgccgacgc agctaaccat gttgtagacg aaattcaaca actgggtggt 180
caggcatttg cctgccgttg tgatattact tccgaacagg aactctctgc actggcagac 240
tttgctatca gtaagctggg taaagttgat attctggtta acaacgccgg tggcggtgga 300
cctaaaccgt ttgatatgcc aatggcggat tttcgccgtg cttatgaact gaatgtgttt 360
tcttttttcc atctgtcaca acttgttgcg ccagaaatgg aaaaaaatgg cggtggcgtt 420
attctgacca tcacttctat ggcggcagaa aataaaaata taaacatgac ttcctatgca 480
tcatctaaag ctgcggccag tcatctggtc agaaatatgg cgtttgacct gggtgaaaaa 540
aatattcggg taaatggcat tgcgccgggg gcaatattaa ccgatgccct gaaatccgtt 600
attacaccag aaattgaaca aaaaatgtta cagcacacgc cgatcagacg tctgggccaa 660
ccgcaagata ttgctaacgc agcgctgttc ctttgctcgc ctgctgcgag ctgggtaagc 720
ggacaaattc tcaccgtctc cggtggtggg gtacaggagc tcaattaa 768
<210> 6
<211> 255
<212> PRT
<213> 大肠埃希氏杆菌(Escherichia coli)
<400> 6
Met Phe Asn Ser Asp Asn Leu Arg Leu Asp Gly Lys Cys Ala Ile Ile
1 5 10 15
Thr Gly Ala Gly Ala Gly Ile Gly Lys Glu Ile Ala Ile Thr Phe Ala
20 25 30
Thr Ala Gly Ala Ser Val Val Val Ser Asp Ile Asn Ala Asp Ala Ala
35 40 45
Asn His Val Val Asp Glu Ile Gln Gln Leu Gly Gly Gln Ala Phe Ala
50 55 60
Cys Arg Cys Asp Ile Thr Ser Glu Gln Glu Leu Ser Ala Leu Ala Asp
65 70 75 80
Phe Ala Ile Ser Lys Leu Gly Lys Val Asp Ile Leu Val Asn Asn Ala
85 90 95
Gly Gly Gly Gly Pro Lys Pro Phe Asp Met Pro Met Ala Asp Phe Arg
100 105 110
Arg Ala Tyr Glu Leu Asn Val Phe Ser Phe Phe His Leu Ser Gln Leu
115 120 125
Val Ala Pro Glu Met Glu Lys Asn Gly Gly Gly Val Ile Leu Thr Ile
130 135 140
Thr Ser Met Ala Ala Glu Asn Lys Asn Ile Asn Met Thr Ser Tyr Ala
145 150 155 160
Ser Ser Lys Ala Ala Ala Ser His Leu Val Arg Asn Met Ala Phe Asp
165 170 175
Leu Gly Glu Lys Asn Ile Arg Val Asn Gly Ile Ala Pro Gly Ala Ile
180 185 190
Leu Thr Asp Ala Leu Lys Ser Val Ile Thr Pro Glu Ile Glu Gln Lys
195 200 205
Met Leu Gln His Thr Pro Ile Arg Arg Leu Gly Gln Pro Gln Asp Ile
210 215 220
Ala Asn Ala Ala Leu Phe Leu Cys Ser Pro Ala Ala Ser Trp Val Ser
225 230 235 240
Gly Gln Ile Leu Thr Val Ser Gly Gly Gly Val Gln Glu Leu Asn
245 250 255
<210> 7
<211> 990
<212> DNA
<213> Streptococcus
<400> 7
atgaaactcg ccgtttatag cacaaaacag tacgacaaga agtacctgca acaggtgaac 60
gagtcctttg gctttgagct ggaatttttt gactttctgc tgacggaaaa aaccgctaaa 120
actgccaatg gctgcgaagc ggtatgtatt ttcgtaaacg atgacggcag ccgcccggtg 180
ctggaagagc tgaaaaagca cggcgttaaa tatatcgccc tgcgctgtgc cggtttcaat 240
aacgtcgacc ttgacgcggc aaaagaactg gggctgaaag tagtccgtgt tccagcctat 300
gatccagagg ccgttgctga acacgccatc ggtatgatga tgacgctgaa ccgccgtatt 360
caccgcgcgt atcagcgtac ccgtgatgct aacttctctc tggaaggtct gaccggcttt 420
actatgtatg gcaaaacggc aggcgttatc ggtaccggta aaatcggtgt ggcgatgctg 480
cgcattctga aaggttttgg tatgcgtctg ctggcgttcg atccgtatcc aagtgcagcg 540
gcgctggaac tcggtgtgga gtatgtcgat ctgccaaccc tgttctctga atcagacgtt 600
atctctctgc actgcccgct gacaccggaa aactatcatc tgttgaacga agccgccttc 660
gaacagatga aaaatggcgt gatgatcgtc aataccagtc gcggtgcatt gattgattct 720
caggcagcaa ttgaagcgct gaaaaatcag aaaattggtt cgttgggtat ggacgtgtat 780
gagaacgaac gcgatctatt ctttgaagat aaatccaacg acgtgatcca ggatgacgta 840
ttccgtcgcc tgtctgcctg ccacaacgtg ctgtttaccg ggcaccaggc attcctgaca 900
gcagaagctc tgaccagtat ttctcagact acgctgcaaa acttaagcaa tctggaaaaa 960
ggcgaaacct gcccgaacga actggtttaa 990
<210> 8
<211> 329
<212> PRT
<213> Streptococcus
<400> 8
Met Lys Leu Ala Val Tyr Ser Thr Lys Gln Tyr Asp Lys Lys Tyr Leu
1 5 10 15
Gln Gln Val Asn Glu Ser Phe Gly Phe Glu Leu Glu Phe Phe Asp Phe
20 25 30
Leu Leu Thr Glu Lys Thr Ala Lys Thr Ala Asn Gly Cys Glu Ala Val
35 40 45
Cys Ile Phe Val Asn Asp Asp Gly Ser Arg Pro Val Leu Glu Glu Leu
50 55 60
Lys Lys His Gly Val Lys Tyr Ile Ala Leu Arg Cys Ala Gly Phe Asn
65 70 75 80
Asn Val Asp Leu Asp Ala Ala Lys Glu Leu Gly Leu Lys Val Val Arg
85 90 95
Val Pro Ala Tyr Asp Pro Glu Ala Val Ala Glu His Ala Ile Gly Met
100 105 110
Met Met Thr Leu Asn Arg Arg Ile His Arg Ala Tyr Gln Arg Thr Arg
115 120 125
Asp Ala Asn Phe Ser Leu Glu Gly Leu Thr Gly Phe Thr Met Tyr Gly
130 135 140
Lys Thr Ala Gly Val Ile Gly Thr Gly Lys Ile Gly Val Ala Met Leu
145 150 155 160
Arg Ile Leu Lys Gly Phe Gly Met Arg Leu Leu Ala Phe Asp Pro Tyr
165 170 175
Pro Ser Ala Ala Ala Leu Glu Leu Gly Val Glu Tyr Val Asp Leu Pro
180 185 190
Thr Leu Phe Ser Glu Ser Asp Val Ile Ser Leu His Cys Pro Leu Thr
195 200 205
Pro Glu Asn Tyr His Leu Leu Asn Glu Ala Ala Phe Glu Gln Met Lys
210 215 220
Asn Gly Val Met Ile Val Asn Thr Ser Arg Gly Ala Leu Ile Asp Ser
225 230 235 240
Gln Ala Ala Ile Glu Ala Leu Lys Asn Gln Lys Ile Gly Ser Leu Gly
245 250 255
Met Asp Val Tyr Glu Asn Glu Arg Asp Leu Phe Phe Glu Asp Lys Ser
260 265 270
Asn Asp Val Ile Gln Asp Asp Val Phe Arg Arg Leu Ser Ala Cys His
275 280 285
Asn Val Leu Phe Thr Gly His Gln Ala Phe Leu Thr Ala Glu Ala Leu
290 295 300
Thr Ser Ile Ser Gln Thr Thr Leu Gln Asn Leu Ser Asn Leu Glu Lys
305 310 315 320
Gly Glu Thr Cys Pro Asn Glu Leu Val
325
<210> 9
<211> 792
<212> DNA
<213> Ruminococcus
<400> 9
atgacattga gagaaaaata tggagaatgg ggaattattt taggcgctac tgaaggtgtc 60
ggaaaagcat tttgtgaaag gcttgccaaa gaaggtatga atgtcgtaat ggtcggacgc 120
cgtgaagaaa aattaaaaga gctcggtgag gaactaaaaa acacttatga gattgattat 180
aaagtcgtaa aagcagactt ttcgctgcca gatgctactg acaaaatttt tgctgcaaca 240
gaaaatctgg atatgggatt tatggcctat gtagcctgct tacactcttt tggcaaaatc 300
caggatacac cttgggaaaa gcatgaggca atgatcaacg taaacgttgt tacatttatg 360
aaatgcttct atcactatat gaaaatcttt gctgcacagg atcgcggtgc tgtcatcaac 420
gtatcttcta tgactggaat ttccagttca ccatggaatg gccaatatgg tgcaggaaag 480
gcattcattt taaaaatgac agaggctgtt gcctgtgaaa cggaaaagac caatgttgat 540
gtggaagtca tcactttggg aactactctg acaccaagtc ttttaagcaa cctgcctggc 600
ggaccacagg gggaagctgt tatgaagact gctcaaacac cggaagaagt tgtggacgaa 660
gcttttgaaa aattaggaaa agaactgtct gtcatttccg gagagcgtaa taaagccagc 720
gtccatgact ggaaagcgaa tcatacagaa gatgactata tccgctatat gggatctttc 780
tatcaagaat aa 792
<210> 10
<211> 263
<212> PRT
<213> Ruminococcus
<400> 10
Met Thr Leu Arg Glu Lys Tyr Gly Glu Trp Gly Ile Ile Leu Gly Ala
1 5 10 15
Thr Glu Gly Val Gly Lys Ala Phe Cys Glu Arg Leu Ala Lys Glu Gly
20 25 30
Met Asn Val Val Met Val Gly Arg Arg Glu Glu Lys Leu Lys Glu Leu
35 40 45
Gly Glu Glu Leu Lys Asn Thr Tyr Glu Ile Asp Tyr Lys Val Val Lys
50 55 60
Ala Asp Phe Ser Leu Pro Asp Ala Thr Asp Lys Ile Phe Ala Ala Thr
65 70 75 80
Glu Asn Leu Asp Met Gly Phe Met Ala Tyr Val Ala Cys Leu His Ser
85 90 95
Phe Gly Lys Ile Gln Asp Thr Pro Trp Glu Lys His Glu Ala Met Ile
100 105 110
Asn Val Asn Val Val Thr Phe Met Lys Cys Phe Tyr His Tyr Met Lys
115 120 125
Ile Phe Ala Ala Gln Asp Arg Gly Ala Val Ile Asn Val Ser Ser Met
130 135 140
Thr Gly Ile Ser Ser Ser Pro Trp Asn Gly Gln Tyr Gly Ala Gly Lys
145 150 155 160
Ala Phe Ile Leu Lys Met Thr Glu Ala Val Ala Cys Glu Thr Glu Lys
165 170 175
Thr Asn Val Asp Val Glu Val Ile Thr Leu Gly Thr Thr Leu Thr Pro
180 185 190
Ser Leu Leu Ser Asn Leu Pro Gly Gly Pro Gln Gly Glu Ala Val Met
195 200 205
Lys Thr Ala Gln Thr Pro Glu Glu Val Val Asp Glu Ala Phe Glu Lys
210 215 220
Leu Gly Lys Glu Leu Ser Val Ile Ser Gly Glu Arg Asn Lys Ala Ser
225 230 235 240
Val His Asp Trp Lys Ala Asn His Thr Glu Asp Asp Tyr Ile Arg Tyr
245 250 255
Met Gly Ser Phe Tyr Gln Glu
260
<210> 11
<211> 786
<212> DNA
<213> Bacillus
<400> 11
atgtatacag atttaaaaga taaagtagtt gtaattacag gtggatcaac aggtttagga 60
cgcgcaatgg ctgttcgttt cggtcaagaa gaagcaaaag ttgttattaa ctattacaac 120
aatgaagaag aagctttaga tgcgaaaaaa gaagtagaag aagcaggcgg acaagcaatc 180
atcgttcaag gcgacgtaac aaaagaagaa gatgttgtaa accttgttca aacagctatt 240
aaagaattcg gtacattaga cgttatgatt aataacgctg gtgttgaaaa cccagttcct 300
tctcatgagt tatctttaga caactggaat aaagtaatcg atacaaactt aacgggcgca 360
tttttaggaa gccgcgaagc gattaaatat tttgttgaaa acgacattaa aggaaacgtt 420
attaacatgt ctagtgttca tgaaatgatt ccttggccat tatttgttca ttacgcagca 480
agtaaaggcg gtatgaaact aatgacgaaa acattggctc ttgaatatgc gccaaaaggt 540
atccgcgtaa ataacattgg accaggtgcg atgaacacac caattaacgc agagaaattt 600
gcagatcctg tacaacgtgc agacgtagaa agcatgattc caatgggtta catcggtaaa 660
ccagaagaag tagcagcagt tgcagcattc ttagcatcat cacaagcaag ctatgtaaca 720
ggtattacat tatttgctga tggtggtatg acgctgtacc cttctttcca agcaggaaga 780
ggctaa 786
<210> 12
<211> 261
<212> PRT
<213> Bacillus
<400> 12
Met Tyr Thr Asp Leu Lys Asp Lys Val Val Val Ile Thr Gly Gly Ser
1 5 10 15
Thr Gly Leu Gly Arg Ala Met Ala Val Arg Phe Gly Gln Glu Glu Ala
20 25 30
Lys Val Val Ile Asn Tyr Tyr Asn Asn Glu Glu Glu Ala Leu Asp Ala
35 40 45
Lys Lys Glu Val Glu Glu Ala Gly Gly Gln Ala Ile Ile Val Gln Gly
50 55 60
Asp Val Thr Lys Glu Glu Asp Val Val Asn Leu Val Gln Thr Ala Ile
65 70 75 80
Lys Glu Phe Gly Thr Leu Asp Val Met Ile Asn Asn Ala Gly Val Glu
85 90 95
Asn Pro Val Pro Ser His Glu Leu Ser Leu Asp Asn Trp Asn Lys Val
100 105 110
Ile Asp Thr Asn Leu Thr Gly Ala Phe Leu Gly Ser Arg Glu Ala Ile
115 120 125
Lys Tyr Phe Val Glu Asn Asp Ile Lys Gly Asn Val Ile Asn Met Ser
130 135 140
Ser Val His Glu Met Ile Pro Trp Pro Leu Phe Val His Tyr Ala Ala
145 150 155 160
Ser Lys Gly Gly Met Lys Leu Met Thr Lys Thr Leu Ala Leu Glu Tyr
165 170 175
Ala Pro Lys Gly Ile Arg Val Asn Asn Ile Gly Pro Gly Ala Met Asn
180 185 190
Thr Pro Ile Asn Ala Glu Lys Phe Ala Asp Pro Val Gln Arg Ala Asp
195 200 205
Val Glu Ser Met Ile Pro Met Gly Tyr Ile Gly Lys Pro Glu Glu Val
210 215 220
Ala Ala Val Ala Ala Phe Leu Ala Ser Ser Gln Ala Ser Tyr Val Thr
225 230 235 240
Gly Ile Thr Leu Phe Ala Asp Gly Gly Met Thr Leu Tyr Pro Ser Phe
245 250 255
Gln Ala Gly Arg Gly
260

Claims (7)

1.工程菌7α-HSDH-LDH-ΔmazG BW25113,其特征在于,
所述工程菌7α-HSDH-LDH-ΔmazG BW25113由含有7α-HSDH基因片段和LDH基因片段的质粒载体转入敲除mazG基因片段的底盘菌株中获得;
所述含有7α-HSDH基因片段和LDH基因片段的质粒载体是由7α-HSDH基因和LDH基因导入pBAD质粒载体获得;
所述敲除mazG基因片段的底盘菌株是由大肠杆菌BW25113菌株敲除mazG基因获得;
所述7α-HSDH基因具有SEQ ID NO.6所示的氨基酸序列;
所述LDH基因具有SEQ ID NO.8所示的氨基酸序列;
所述mazG基因具有SEQ ID NO.2所示的氨基酸序列。
2.全细胞催化CDCA生产UDCA的方法,其特征在于,包括如下步骤:
权利要求1所述工程菌7α-HSDH-LDH-ΔmazG BW25113催化鹅去氧胆酸转变成中间体7-酮石胆酸;
工程菌7β-HSDH-GDH-Δpgi BW25113催化中间体7-酮石胆酸转变成熊去氧胆酸。
3.依据权利要求2所述的全细胞催化CDCA生产UDCA的方法,其特征在于,
所述工程菌7α-HSDH-LDH-ΔmazG BW25113催化鹅去氧胆酸转变成中间体7-酮石胆酸包括如下步骤:
PB缓冲溶液中加入全细胞催化剂菌体7α-HSDH-LDH-ΔmazG BW25113,加入CDCA和丙酮酸钠,控制反应条件生成中间体7-酮石胆酸。
4.依据权利要求2所述的全细胞催化CDCA生产UDCA的方法,其特征在于,
所述工程菌7β-HSDH-GDH-Δpgi BW25113催化中间体7-酮石胆酸转变成熊去氧胆酸包括如下步骤:
在中间体7-酮石胆酸的反应溶液中加入工程菌7β-HSDH-GDH-Δpgi BW25113,加入葡萄糖,控制反应条件生成熊去氧胆酸。
5.依据权利要求2所述的全细胞催化CDCA生产UDCA的方法,其特征在于,
所述工程菌7α-HSDH-LDH-ΔmazG BW25113与CDCA加入的质量比为1:3。
6.依据权利要求2所述的全细胞催化CDCA生产UDCA的方法,其特征在于,
所述反应条件的pH值为7.5、温度为30℃。
7.依据权利要求2所述的全细胞催化CDCA生产UDCA的方法,其特征在于,
所述工程菌7β-HSDH-GDH-Δpgi BW25113由含有7β-HSDH基因片段和GDH基因片段的质粒载体转入敲除pgi基因片段的底盘菌株中获得;
所述含有7β-HSDH基因片段和GDH基因片段的质粒载体是由7β-HSDH基因和GDH基因导入pBAD质粒载体获得;
所述敲除pgi基因片段的底盘菌株是由大肠杆菌BW25113菌株敲除pgi基因获得;
所述7β-HSDH基因具有SEQ ID NO.10所示的氨基酸序列;
所述GDH基因具有SEQ ID NO.12所示的氨基酸序列;
所述pgi基因具有SEQ ID NO.4所示的氨基酸序列。
CN202210556251.2A 2022-05-20 2022-05-20 工程菌及其高效催化cdca生产udca的方法 Active CN114940964B (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202210556251.2A CN114940964B (zh) 2022-05-20 2022-05-20 工程菌及其高效催化cdca生产udca的方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202210556251.2A CN114940964B (zh) 2022-05-20 2022-05-20 工程菌及其高效催化cdca生产udca的方法

Publications (2)

Publication Number Publication Date
CN114940964A true CN114940964A (zh) 2022-08-26
CN114940964B CN114940964B (zh) 2024-04-05

Family

ID=82909301

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202210556251.2A Active CN114940964B (zh) 2022-05-20 2022-05-20 工程菌及其高效催化cdca生产udca的方法

Country Status (1)

Country Link
CN (1) CN114940964B (zh)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114134067A (zh) * 2021-10-19 2022-03-04 山东睿智医药科技有限公司 一种大肠杆菌及应用

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105368828A (zh) * 2015-11-04 2016-03-02 南京普瑞特生物科技有限公司 一种高效全细胞催化鹅去氧胆酸合成熊去氧胆酸的方法
CN107385006A (zh) * 2017-09-04 2017-11-24 苏州笃美生物科技有限公司 一种化学细胞催化ca合成udca的方法
CN109402212A (zh) * 2018-11-29 2019-03-01 江苏邦泽生物医药技术股份有限公司 生物转化制备牛磺熊去氧胆酸的方法及其应用
CN112029739A (zh) * 2020-09-15 2020-12-04 江西邦泰绿色生物合成生态产业园发展有限公司 7β羟基类固醇脱氢酶突变体及其在制备UDCA中的应用
CN112725212A (zh) * 2021-01-15 2021-04-30 江南大学 高效转化鹅去氧胆酸的重组酵母底盘细胞改造及重组菌株构建与应用

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105368828A (zh) * 2015-11-04 2016-03-02 南京普瑞特生物科技有限公司 一种高效全细胞催化鹅去氧胆酸合成熊去氧胆酸的方法
CN107385006A (zh) * 2017-09-04 2017-11-24 苏州笃美生物科技有限公司 一种化学细胞催化ca合成udca的方法
CN109402212A (zh) * 2018-11-29 2019-03-01 江苏邦泽生物医药技术股份有限公司 生物转化制备牛磺熊去氧胆酸的方法及其应用
CN112029739A (zh) * 2020-09-15 2020-12-04 江西邦泰绿色生物合成生态产业园发展有限公司 7β羟基类固醇脱氢酶突变体及其在制备UDCA中的应用
CN112725212A (zh) * 2021-01-15 2021-04-30 江南大学 高效转化鹅去氧胆酸的重组酵母底盘细胞改造及重组菌株构建与应用

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114134067A (zh) * 2021-10-19 2022-03-04 山东睿智医药科技有限公司 一种大肠杆菌及应用

Also Published As

Publication number Publication date
CN114940964B (zh) 2024-04-05

Similar Documents

Publication Publication Date Title
KR102652526B1 (ko) 생물 전환으로 타우로우루소데옥시콜산을 제조하는 방법 및 그 응용
CN113528472B (zh) 一种细胞色素p450 bm3突变体及其在醋酸群勃龙合成中的应用
CN112662637B (zh) 一种甲酸脱氢酶突变体及其制备方法和应用
CN114015712A (zh) 一种熊去氧胆酸的制备方法
CN113337450A (zh) 一种大肠杆菌基因工程菌、构建方法以及全细胞催化生产(r)-香茅醛的方法
CN114940964B (zh) 工程菌及其高效催化cdca生产udca的方法
CN114134134B (zh) L-苏氨酸醛缩酶突变体及其在合成L-syn-对甲砜基苯丝氨酸中的应用
CN106119180B (zh) 一种分枝杆菌重组基因工程菌及其应用
CN110628735B (zh) 一种5α-还原酶突变体,基因工程菌及其在高效催化5α-AD生产中的应用
CN111454918B (zh) 一种烯醇还原酶突变体及其在制备(r)-香茅醛中的应用
CN114891707B (zh) 重组菌株及其全细胞催化生产胆红素的方法
CN109679978B (zh) 一种用于制备l-2-氨基丁酸的重组共表达体系及其应用
JP2023133181A (ja) 組換え大腸菌および高純度ウルソデオキシコール酸の調製方法
CN116814572A (zh) 一种羰基还原酶及其突变体及其在制备手性(r)-8-氯-6-羟基辛酸乙酯中的应用
CN114854707B (zh) 一种7β-羟基甾体脱氢酶突变体
CN111172089A (zh) 一种利用重组海藻糖合成酶合成海藻糖的方法
CN114507650B (zh) 亮氨酸脱氢酶突变体及其在合成(s)-邻氯苯甘氨酸中的应用
CN113930457B (zh) 一种双酶偶联合成(s)-香茅醇的方法
CN113583985B (zh) 一种可以在毕赤酵母高效分泌的单加氧酶突变体及应用
CN116286562A (zh) 一种基因工程菌及其制备方法和应用
CN114277023A (zh) 重组腈水合酶及其在耦合离子交换树脂制备烟酰胺中的应用
CN110591997A (zh) 一种提高木糖酸脱水酶活性的基因工程菌及其构建方法与应用
CN112813041B (zh) 一种分枝杆菌的17β-羟基类固醇脱氢酶突变体和工程菌及其应用
CN115786292B (zh) 一种3β-羟基甾体脱氢酶及其在制备去氢表雄酮中的应用
CN113174377B (zh) 羰基还原酶、突变体及其在制备地尔硫卓中间体中的应用

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant